Brief: Collplant Biotechnologies Reports 2025 Third Quarter Financial Results
26/11/2025 12:41
Nov 26 (Reuters) - Collplant Biotechnologies Ltd CPTG.F: COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE COLLPLANT BIOTECHNOLOGIES 9M OPERATING EXPENSES USD 10 MILLION COLLPLANT BIOTECHNOLOGIES 9M ADJUSTED NET INCOME USD -7 MILLION COLLPLANT BIOTECHNOLOGIES 9M ADJUSTED EPS USD -0.58 COLLPLANT BIOTECHNOLOGIES 9M REVENUE USD 2.3 MILLION COLLPLANT BIOTECHNOLOGIES 9M NET INCOME USD -8.3 MILLION COLLPLANT BIOTECHNOLOGIES 9M EPS USD -0.69 COLLPLANT BIOTECHNOLOGIES LTD - RECENTLY UPDATED ITS EXPENSE FORECAST AND HAS INITIATED A COST CUTTING AND WORKFORCE REDUCTION PLAN COLLPLANT BIOTECHNOLOGIES: UPDATED ALLOCATION OF RESOURCES TO RESULT IN REDUCTION IN WORKFORCE BY ABOUT 25% COLLPLANT BIOTECHNOLOGIES LTD - ROGER POMERANTZ STEPS DOWN AS CHAIRMAN; YEHIEL TAL NOMINATED AS INTERIM CHAIRMAN COLLPLANT BIOTECHNOLOGIES LTD - ROGER POMERANTZ STEPS DOWN AS CHAIRMAN; YEHIEL TAL NOMINATED AS INTERIM CHAIRMAN Source text: ID:nPn9sb26Va Further company coverage: CPTG.F ((Reuters.Briefs@thomsonreuters.com;))